Data / Research funding / Natural Products
Natural Products: 856 NIH awards ($1.1B) to 277 organizations
856 NIH awards ($1.1B) in the NIH spending category Natural Products, to 277 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 856 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $21,254,211 | September 6, 2024 | September 5, 2026 | HANANIA, TALEEN | reporter.nih.gov |
| West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,261,619 | September 30, 2001 | July 31, 2029 | JOSHI, TRUPTI | reporter.nih.gov |
| Discovery of Chemical Probes and Therapeutic Leads, Phase II | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $12,886,039 | September 1, 2014 | June 30, 2026 | FOX, JOSEPH M | reporter.nih.gov |
| Cannabidiol in the treatment of opioid use disorder | NIH | National Institute on Drug Abuse | 2024 | $10,316,590 | September 30, 2019 | August 31, 2027 | HURD, YASMIN L. | reporter.nih.gov |
| TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024. | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,957,809 | August 30, 2023 | August 29, 2026 | ROTH, BRYAN | reporter.nih.gov |
| Rocky Mountain Cannabis Research Center | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,380,548 | September 1, 2023 | June 30, 2028 | HUTCHISON, KENT E. | reporter.nih.gov |
| Development of SBS-226, a MOR agonist / DOR antagonist, for OUD | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,941,988 | September 30, 2024 | August 31, 2027 | REICH, JEFFREY | reporter.nih.gov |
| Microbial Chemical Sensing and Host Responses | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $7,729,035 | April 1, 2021 | June 30, 2026 | CRAWFORD, JASON MICHAEL | reporter.nih.gov |
| REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT | NIH | National Cancer Institute | 2023 to 2025 | $7,231,030 | March 1, 2024 | February 28, 2025 | SCHROCK, RICHARD | reporter.nih.gov |
| Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,084,951 | May 15, 2023 | March 31, 2028 | NDHLOVU, LISHOMWA C | reporter.nih.gov |
| Integrative Multidisciplinary Discovery Platform to Unlock Marine Natural Products Therapeutic Opportunities | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $7,069,063 | August 1, 2022 | July 31, 2027 | LUESCH, HENDRIK | reporter.nih.gov |
| PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial | NIH | National Institute on Aging | 2022 to 2025 | $6,295,083 | February 15, 2022 | January 31, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Natural products as probes of the pain pathway | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,820,560 | December 15, 2017 | November 30, 2025 | JULIUS, DAVID | reporter.nih.gov |
| Scalable Synthesis and New Bond Disconnections | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,750,475 | April 1, 2016 | November 30, 2026 | BARAN, PHIL S | reporter.nih.gov |
| Drug Induced Liver Injury Network Data Coordinating Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $5,081,421 | September 30, 2003 | July 31, 2028 | BARNHART, HUIMAN X | reporter.nih.gov |
| Achieving specificity in imaging neurodegeneration with visible light Optical Coherence Tomography | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,798,178 | September 15, 2024 | September 14, 2027 | SRINIVASAN, VIVEK JAY | reporter.nih.gov |
| Opioid use disorders: UF Pharmacy medications discovery and development | NIH | National Institute on Drug Abuse | 2021 to 2023 | $4,479,677 | December 15, 2018 | November 30, 2024 | MCCURDY, CHRISTOPHER R | reporter.nih.gov |
| Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,324,439 | May 1, 2021 | July 31, 2026 | MINASSIAN, ARPI | reporter.nih.gov |
| TrmD-targeting actinobacterial natural products as next generation antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,187,325 | June 25, 2021 | May 31, 2027 | HOU, YA-MING | reporter.nih.gov |
| Site-Selective Catalysis for Bioactive Scaffold Diversification | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,180,650 | June 1, 2019 | May 31, 2029 | MILLER, SCOTT J | reporter.nih.gov |
| Unified Computation Tools for Natural Products research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,056,858 | September 5, 2013 | August 31, 2029 | GERWICK, WILLIAM HENRY | reporter.nih.gov |
| Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,954,829 | April 15, 2011 | June 30, 2027 | ICHTCHENKO, KONSTANTIN | reporter.nih.gov |
| Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,931,875 | June 1, 2021 | March 31, 2027 | LOGGIA, MARCO LUCIANO | reporter.nih.gov |
| The Center for High Content Functional Annotation of Natural Products | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $3,906,784 | September 1, 2015 | June 30, 2025 | MACMILLAN, JOHN B | reporter.nih.gov |
| The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,815,411 | February 1, 2010 | April 30, 2028 | MISRA, SANJAY | reporter.nih.gov |
| A Next-Generation Scalable Platform to Discover Antimicrobials of Ribosomal Origin | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,775,416 | March 25, 2019 | May 31, 2029 | ZHAO, HUIMIN | reporter.nih.gov |
| Unusual Pharmacophores and New Tools for Cross-Coupling | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,734,184 | April 1, 2017 | March 31, 2027 | SHENVI, RYAN ASHOK | reporter.nih.gov |
| Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,726,178 | August 15, 2023 | June 30, 2028 | IUDICELLO, JENNIFER E | reporter.nih.gov |
| Chemical Synthesis of Complex Natural Products for Translational Science | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,701,049 | May 1, 2016 | August 31, 2026 | PORCO, JOHN A. | reporter.nih.gov |
| Understanding the role of senescence on post-operative neuroinflammation | NIH | National Institute on Aging | 2022 to 2025 | $3,674,270 | September 15, 2022 | August 31, 2027 | VARGHESE, SHYNI | reporter.nih.gov |
| Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $3,588,425 | March 1, 2024 | October 17, 2025 | MAREK, GERARD JOSEPH | reporter.nih.gov |
| Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,584,464 | June 15, 2022 | March 31, 2027 | ELLIS, RONALD J. | reporter.nih.gov |
| Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $3,579,362 | September 18, 2023 | August 31, 2028 | BRUMMETT, CHAD M | reporter.nih.gov |
| Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,529,874 | August 1, 2020 | May 31, 2027 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,521,973 | August 31, 2024 | April 30, 2027 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Metalloenzymes and metal homeostasis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,495,303 | April 1, 2016 | March 31, 2026 | ROSENZWEIG, AMY C. | reporter.nih.gov |
| Renewal: Strategies and Methods for Complex Molecule Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,491,989 | January 1, 2019 | December 31, 2027 | SARPONG, RICHMOND | reporter.nih.gov |
| Development of New Strategies for Chemical Synthesis and Study of Complex Natural Products | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,479,127 | May 1, 2021 | May 31, 2026 | MOVASSAGHI, MOHAMMAD | reporter.nih.gov |
| Characteristics of Botulinum Neurotoxins the Determine Potency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,427,741 | January 18, 2019 | June 30, 2029 | PELLETT, SABINE | reporter.nih.gov |
| Molecular underpinnings of the developmental Effects of Cannabis | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,375,521 | August 15, 2022 | May 31, 2027 | HURD, YASMIN L. | reporter.nih.gov |
| COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial | NIH | National Institute on Aging | 2021 to 2025 | $3,367,372 | July 1, 2021 | June 30, 2027 | MCDERMOTT, MARY MCGRAE | reporter.nih.gov |
| Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatment | NIH | National Cancer Institute | 2023 to 2025 | $3,343,401 | September 19, 2023 | August 31, 2028 | POTOSKY, ARNOLD L | reporter.nih.gov |
| Exploiting Unconventional Building Blocks in Chemical Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,314,724 | February 1, 2021 | July 31, 2025 | GARG, NEIL K. | reporter.nih.gov |
| Targeted Delivery of Therapeutics into Motor Neurons for Post-exposure Treatment of Botulism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,307,348 | August 1, 2021 | July 31, 2027 | DONG, MIN | reporter.nih.gov |
| Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,267,557 | September 30, 2020 | June 30, 2026 | MOHAN, MAHESH | reporter.nih.gov |
| NP-MRD: Natural Products Magnetic Resonance Database | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $3,264,473 | July 1, 2020 | June 30, 2026 | CORT, JOHN R | reporter.nih.gov |
| MIRA: Enzymology and Self-Resistance of Natural Product Biosynthesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,260,469 | May 1, 2016 | March 31, 2026 | TANG, YI | reporter.nih.gov |
| Indoles from commensal microbiota promote mobility during aging | NIH | National Institute on Aging | 2025 | $3,251,767 | September 1, 2025 | August 31, 2029 | KALMAN, DANIEL | reporter.nih.gov |
| Effects of full-spectrum cannabidiol on alcohol consumption and alcohol use disorder phenotypes: implications for precision medicine | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $3,227,517 | September 20, 2025 | August 31, 2029 | KAROLY, HOLLIS C | reporter.nih.gov |
| Synthesis and Evaluation of Carbohydrate Vaccine Adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,192,190 | June 10, 2022 | May 31, 2027 | NGUYEN, HIEN M | reporter.nih.gov |
| Peripherally-restricted non-addictive cannabinoids for cancer pain treatment | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $3,174,343 | August 1, 2023 | July 31, 2025 | SPIGELMAN, IGOR | reporter.nih.gov |
| ERP studies of acute influences of THC and CBD on memory encoding and retrieval processes | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,173,683 | August 1, 2021 | May 31, 2027 | CURRAN, TIMOTHY E | reporter.nih.gov |
| Neural and Behavioral Consequences of Chronic THC Exposure During Adolescence | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,173,342 | July 1, 2019 | March 31, 2030 | BERGMAN, JACK | reporter.nih.gov |
| Chemical Synthesis of Chiral Bioactive Molecules | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,165,278 | May 1, 2016 | June 30, 2026 | REISMAN, SARAH ELIZABETH | reporter.nih.gov |
| Modulation of pain mechanisms by cannabis-derived phytochemicals. | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,150,461 | December 1, 2020 | November 30, 2026 | SETO, TODD B | reporter.nih.gov |
| Macrophage senescence as a driver of granuloma failure and progression to necrosis in TB and TB/HIV | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,145,850 | September 19, 2025 | August 31, 2029 | BISHAI, WILLIAM RAMSES | reporter.nih.gov |
| Genomics-Assisted Antibiotic Discovery from Unprecedented Microbes of the Great Salt Lake | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,135,301 | July 12, 2021 | April 30, 2027 | WINTER, JACLYN MARIE | reporter.nih.gov |
| Microbiota, Metabolites, and Colon Neoplasia | NIH | National Cancer Institute | 2021 to 2025 | $3,124,761 | May 1, 2021 | April 30, 2027 | ROSENBERG, DANIEL WILLIAM | reporter.nih.gov |
| GENETIC TOXICOLOGY SUPPORT FOR THE NTP AND THE NIEHS | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $3,123,963 | September 6, 2020 | September 5, 2025 | HOBBS, CHERYL A. | reporter.nih.gov |
| Discriminative Stimulus Effects of Opioid Withdrawal | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,097,773 | May 1, 1995 | December 31, 2026 | FRANCE, CHARLES P | reporter.nih.gov |
| Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and ß-caryophyllene | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,089,484 | February 15, 2020 | January 31, 2026 | COOPER, ZIVA D | reporter.nih.gov |
| MAEVE: Microbiota mediated flavonoid metabolites for cognitive health | NIH | National Institute on Aging | 2024 to 2025 | $3,084,260 | July 15, 2024 | June 30, 2029 | CHURCH, ARPANA | reporter.nih.gov |
| Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,077,792 | September 23, 2020 | August 31, 2025 | KIRBY, JAMES E | reporter.nih.gov |
| Computation and Development of New, Enabling Synthetic Methods | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,060,360 | June 1, 2019 | May 31, 2029 | KOZLOWSKI, MARISA C | reporter.nih.gov |
| Cannabis use among older adults: Potential risks and benefits to an aging population | NIH | National Institute on Aging | 2021 to 2025 | $3,055,285 | February 15, 2021 | January 31, 2027 | BRYAN, ANGELA | reporter.nih.gov |
| Single Cell Methods for Bioeffector Discovery and Analysis | NIH | National Cancer Institute | 2021 to 2025 | $3,031,845 | December 18, 2018 | July 31, 2029 | BACHMANN, BRIAN O | reporter.nih.gov |
| Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,026,236 | June 1, 2021 | May 31, 2026 | SHIBAO, CYNDYA ADRIANA | reporter.nih.gov |
| Novel Antimalarials from Fungi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,025,049 | May 18, 2020 | April 30, 2026 | CHAKRABARTI, DEBOPAM | reporter.nih.gov |
| Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,015,316 | March 4, 2022 | February 28, 2027 | ANDES, DAVID R | reporter.nih.gov |
| AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,004,104 | March 15, 2021 | February 28, 2027 | CISNEROS, IRMA | reporter.nih.gov |
| The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,992,059 | April 1, 2021 | December 31, 2025 | PERSIDSKY, YURI | reporter.nih.gov |
| Synthetic and translational studies of antitumor and antimicrobial natural products. | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,988,144 | May 1, 2019 | April 30, 2029 | HERZON, SETH B. | reporter.nih.gov |
| Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology | NIH | National Institute on Aging | 2021 to 2025 | $2,987,650 | August 15, 2021 | May 31, 2027 | SETLOW, BARRY | reporter.nih.gov |
| Development of KLS-13019 for Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,970,772 | September 30, 2021 | August 31, 2025 | BRENNEMAN, DOUGLAS ERIC | reporter.nih.gov |
| Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,942,798 | July 1, 2022 | December 31, 2025 | WU, CHENGCANG CHARLES | reporter.nih.gov |
| Enhancing Children's Cognitive Function and Achievement through Carotenoid Consumption | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,916,241 | September 17, 2021 | May 31, 2027 | KHAN, NAIMAN | reporter.nih.gov |
| Effect of randomized cocoa supplementation on inflammaging and epigenetic aging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,908,307 | July 15, 2021 | May 31, 2026 | DONG, YANBIN | reporter.nih.gov |
| Targeting PDGFR-b promoter vacancy G-quadruplex to suppress gene expression | NIH | National Cancer Institute | 2025 | $2,906,409 | August 1, 2025 | July 31, 2029 | YANG, DANZHOU | reporter.nih.gov |
| Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement) | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $2,902,023 | September 15, 2019 | June 30, 2025 | HE, ZHIGANG | reporter.nih.gov |
| New Catalysts, Strategies and Methods for Stereoselective Chemical Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,884,150 | January 1, 2019 | July 31, 2029 | HOVEYDA, AMIR H | reporter.nih.gov |
| Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,883,639 | September 30, 2020 | August 31, 2026 | PAPPAS, GEORGE | reporter.nih.gov |
| Cannabinoid interactions with central and peripheral pain mechanisms in osteoarthritis of the knee | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,864,374 | August 1, 2020 | May 31, 2026 | HARTE, STEVEN EDWARD | reporter.nih.gov |
| A New Class of Broad-Spectrum Antibacterial Agents to Treat Multi-Drug Resistant Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,858,436 | July 21, 2023 | June 30, 2027 | SEBAHAR, PAUL | reporter.nih.gov |
| CHEMICAL SYNTHESIS FACILITY FOR CONTRACEPTIVE DEVELOPMENT | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,852,434 | September 29, 2022 | September 28, 2026 | GURVICH, VADIM | reporter.nih.gov |
| Opioid and cannabinoid interactions in pain and reward | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,852,096 | September 30, 2020 | June 30, 2026 | NEUBERT, JOHN K | reporter.nih.gov |
| Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,851,386 | September 30, 2020 | July 31, 2025 | VOLSKY, DAVID J | reporter.nih.gov |
| Discovery and mechanisms of biosynthetic enzymes | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,838,667 | May 1, 2018 | August 31, 2028 | BANDARIAN, VAHE | reporter.nih.gov |
| Supratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue Sarcomas | NIH | National Cancer Institute | 2022 to 2025 | $2,833,313 | August 1, 2022 | July 31, 2027 | RAUT, CHANDRAJIT PREMANAND | reporter.nih.gov |
| Selective C(sp3)-H Oxidations and Functionalizations with Tunable Metal Catalysts for Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,805,104 | May 1, 2017 | April 30, 2027 | WHITE, MARIA CHRISTINA | reporter.nih.gov |
| Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,756,681 | July 1, 2020 | April 30, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| Mechanisms of cannabidiol in persons with MS: the role of sleep and pain phenotype | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,725,289 | August 15, 2021 | May 31, 2026 | BRALEY, TIFFANY JOY | reporter.nih.gov |
| Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,720,537 | September 30, 2022 | June 30, 2027 | SMITH, DANIELLE | reporter.nih.gov |
| New Catalytic Methods for the Synthesis of Complex Molecules | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,719,827 | August 1, 2020 | May 31, 2030 | NICEWICZ, DAVID A | reporter.nih.gov |
| Determining the function of medium to large diameter sensory neurons in paclitaxel-induced pain via large-scale in vivo DRG imaging | NIH | National Cancer Institute | 2025 | $2,714,830 | August 6, 2025 | July 31, 2030 | ZHENG, QIN | reporter.nih.gov |
| COcoa Supplement and Multivitamins Outcomes Study (COSMOS): Effects on Falls and Physical Performance | NIH | National Institute on Aging | 2021 to 2024 | $2,711,621 | May 15, 2021 | February 28, 2026 | LEBOFF, MERYL SUSAN | reporter.nih.gov |
| Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,671,024 | April 1, 2022 | March 31, 2027 | METRIK, JANE | reporter.nih.gov |
| Vaccines Against Botulism | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,665,989 | July 15, 2015 | May 31, 2026 | BARBIERI, JOSEPH T | reporter.nih.gov |
| Chemistry and Pharmacology of Iboga Alkaloids | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,661,356 | June 15, 2020 | December 31, 2025 | SAMES, DALIBOR | reporter.nih.gov |
| Coffee and metabolites modulating the gut microbiome for improved colorectal cancer survival | NIH | National Cancer Institute | 2022 to 2025 | $2,628,801 | June 2, 2022 | May 31, 2027 | SONG, MINGYANG | reporter.nih.gov |
| Discovery of Antibiotics from Soil Microbiomes Using Metagenomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,627,250 | May 1, 2017 | August 31, 2028 | BRADY, SEAN F | reporter.nih.gov |
| Development and validation of a high-throughput MicroED-driven platform technology for natural product discovery | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,613,903 | May 6, 2022 | February 28, 2027 | QUAVE, CASSANDRA LEAH | reporter.nih.gov |
| Systems Genetics Dissection of Non-alcoholic Steatohepatitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,612,818 | July 1, 2019 | March 31, 2028 | LUSIS, ALDONS JAKE | reporter.nih.gov |
| Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,603,837 | August 1, 2022 | June 30, 2027 | LI, CHUN | reporter.nih.gov |
| Microbial Ecology-Guided Discovery of Antibacterial Drugs | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,576,398 | February 7, 2022 | January 31, 2027 | SCHMIDT, ERIC W | reporter.nih.gov |
| Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,570,020 | September 1, 2021 | July 31, 2027 | KAMINSKI, NORBERT E | reporter.nih.gov |
| The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,563,053 | August 1, 2020 | July 31, 2025 | HUARD, JOHNNY | reporter.nih.gov |
| The Synthesis of Bioactive Natural Products as a Driving Force for Discovery in Organic Chemistry | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,542,460 | April 1, 2022 | March 31, 2027 | STOLTZ, BRIAN M | reporter.nih.gov |
| PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health | NIH | National Institute on Aging | 2022 to 2023 | $2,536,705 | September 30, 2022 | August 31, 2025 | RINEHART, JOHN | reporter.nih.gov |
| Cannabis, inflammation, and the brain in persons with HIV | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,527,684 | September 30, 2020 | June 30, 2025 | IUDICELLO, JENNIFER E | reporter.nih.gov |
| Synthesis and Chemical Biology of Bioactive Natural Products | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,523,386 | January 1, 2021 | December 31, 2026 | PIERCE, JOSHUA G. | reporter.nih.gov |
| Cannabinoid CB2 Receptor Structure and Allosteric Modulators | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,521,841 | July 15, 2021 | April 30, 2026 | XIE, XIANG-QUN | reporter.nih.gov |
| Drug-gene-nutraceutical interactions of cannabidiol | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,519,234 | February 22, 2022 | January 31, 2027 | EADON, MICHAEL THOMAS | reporter.nih.gov |
| Bulgecin Template for Potentiation of beta-Lactam Antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,516,168 | July 1, 2020 | June 30, 2025 | MOBASHERY, SHAHRIAR | reporter.nih.gov |
| Cellular Senescence in Neonatal Airways | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,503,972 | July 1, 2022 | June 30, 2027 | PRAKASH, Y. S. | reporter.nih.gov |
| Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use | NIH | National Institute on Drug Abuse | 2022 to 2023 | $2,497,896 | August 1, 2021 | February 29, 2024 | JACOBS, CINDY | reporter.nih.gov |
| Novel Approaches to Opiate Use Reduction | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,469,078 | April 1, 2020 | January 31, 2026 | HUTCHISON, KENT E. | reporter.nih.gov |
| “Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery” | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,461,992 | March 15, 2022 | February 28, 2026 | OLIVERA, BALDOMERO M | reporter.nih.gov |
| TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION | NIH | National Cancer Institute | 2021 to 2024 | $2,460,645 | August 1, 2021 | July 31, 2025 | KABANOV, ALEXANDER V | reporter.nih.gov |
| Behavior-based discovery of small-molecule modulators of neurochemical signaling pathways that underlie addiction | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,427,182 | July 15, 2022 | May 31, 2027 | RINGSTAD, NIELS | reporter.nih.gov |
| Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific Inhibitors | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,417,560 | June 30, 2016 | June 30, 2026 | WUEST, WILLIAM M | reporter.nih.gov |
| Molecular Prosthetics and Lego Chemistry | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,415,883 | June 1, 2016 | February 29, 2028 | BURKE, MARTIN D | reporter.nih.gov |
| Genetic modifiers of the Mediterranean-DASH diet Intervention for Neurodegenerative Delay (MIND) response | NIH | National Institute on Aging | 2021 to 2024 | $2,385,503 | September 15, 2020 | April 30, 2026 | CORNELIS, MARILYN C | reporter.nih.gov |
| Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,376,018 | September 15, 2023 | July 31, 2028 | BIDWELL, L. CINNAMON | reporter.nih.gov |
| Protein-protein interactions in natural product biosynthesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,360,682 | March 1, 2012 | August 31, 2026 | BURKART, MICHAEL D. | reporter.nih.gov |
| Synthesis and Optimization of the Aleutianamine Class of Alkaloids | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,360,261 | September 1, 2022 | June 30, 2026 | HAMANN, MARK T | reporter.nih.gov |
| Translating CBD Treatment for Heroin Addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,349,864 | August 1, 2019 | June 30, 2025 | HURD, YASMIN L. | reporter.nih.gov |
| Mining Actinobacterial Genomes for Natural Product Discovery and Biosynthesis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,333,969 | January 1, 2020 | January 31, 2029 | SHEN, BEN | reporter.nih.gov |
| Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,330,311 | March 17, 2020 | February 28, 2025 | JOHNSTON, JEFFREY NICHOLAS | reporter.nih.gov |
| Biology and Engineering of Botulinum Neurotoxins. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,317,212 | March 1, 2013 | July 31, 2029 | DONG, MIN | reporter.nih.gov |
| Synthesis of Bioactive Small Molecule Building Blocks | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,303,395 | May 1, 2016 | June 30, 2026 | JOHNSON, JEFFREY S | reporter.nih.gov |
| Metallacycle-mediated coupling in stereoselective synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,296,000 | January 1, 2020 | December 31, 2025 | MICALIZIO, GLENN C | reporter.nih.gov |
| The Impact of Cannabidiol (CBD) Health Claims at Point-of-Sale on Consumer Perceptions and Behavior | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,287,873 | July 15, 2021 | May 31, 2027 | WAGONER, KIMBERLY G. | reporter.nih.gov |
| Soy Isoflavones for Inner City Infants at Risk for Asthma (SIRA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,286,643 | April 14, 2021 | March 31, 2028 | KUMAR, RAJESH | reporter.nih.gov |
| Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,266,058 | September 30, 2020 | June 30, 2025 | WILLIAMS, DIONNA WHITNEY | reporter.nih.gov |
| Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,255,717 | August 1, 2022 | July 31, 2027 | DONG, JIXIN | reporter.nih.gov |
| Tryptophan derivatives in EHEC pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,253,769 | August 8, 2022 | January 31, 2027 | SPERANDIO, VANESSA | reporter.nih.gov |
| Harnessing Alkyl Amines and Alkyl Alcohols in Cross-Coupling Reactions | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,250,697 | June 1, 2019 | May 31, 2029 | WATSON, MARY P | reporter.nih.gov |
| Development of natural product inhibitors of Nef for clearance of HIV reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,246,547 | July 1, 2019 | June 30, 2025 | SHERMAN, DAVID H | reporter.nih.gov |
| Identification of gene variants mediating the behavioral and physiological response to THC | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,243,926 | July 1, 2023 | April 30, 2028 | MULLIGAN, MEGAN KATHLEEN | reporter.nih.gov |
| GUARD: A global unbiased antimicrobial discovery platform | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,236,619 | November 7, 2022 | October 31, 2027 | JAYARAMAN, ARUL | reporter.nih.gov |
| Kratom alkaloids: in vitro and in vivo pharmacological mechanisms | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,226,033 | April 15, 2019 | February 28, 2025 | MCCURDY, CHRISTOPHER R | reporter.nih.gov |
| New reagents for C-C and C-N bond formation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,203,498 | July 1, 2021 | April 30, 2026 | LOPCHUK, JUSTIN MATTHEW | reporter.nih.gov |
| Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $2,201,114 | May 20, 2022 | June 25, 2024 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Understanding the clinical pharmacology of marijuana-tobacco co-administration | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,179,609 | May 15, 2023 | February 29, 2028 | ST.HELEN, GIDEON | reporter.nih.gov |
| The Effects of Cannabinoids and Route of Cannabis Administration on Subclinical Cardiovascular Disease Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,169,132 | August 1, 2020 | June 30, 2025 | VIDOT, DENISE CHRISTINA | reporter.nih.gov |
| Caffeine and Postoperative Neurocognitive Recovery | NIH | National Institute on Aging | 2022 to 2025 | $2,166,523 | August 2, 2022 | April 30, 2027 | VLISIDES, PHILLIP ELEAS | reporter.nih.gov |
| Modulating single cell types in the sensory nervous system | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,152,157 | July 1, 2022 | June 30, 2027 | SCHMIDT, ERIC W | reporter.nih.gov |
| Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial | NIH | National Institute on Aging | 2023 to 2025 | $2,143,253 | July 1, 2023 | June 30, 2028 | HUTCHISON, KENT E. | reporter.nih.gov |
| Late Stage Stereochemical Editing to Transform the Synthesis of Bioactive Molecules | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,143,149 | September 23, 2021 | August 31, 2026 | WENDLANDT, ALISON | reporter.nih.gov |
| Role of PXR in drug-elicited cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,135,638 | December 15, 2022 | November 30, 2026 | ZHOU, CHANGCHENG | reporter.nih.gov |
| Mining Cryptic Biosynthetic Gene Clusters for Novel Bioactive Compounds and Biocatalysts | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,126,227 | July 1, 2020 | May 31, 2030 | PARKINSON, ELIZABETH IVY | reporter.nih.gov |
| Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,123,819 | September 15, 2019 | June 30, 2026 | COOPER, ZIVA D | reporter.nih.gov |
| Validation of Retinal Abeta as a Potential Biomarker of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $2,113,690 | September 1, 2019 | November 30, 2025 | PHAM, WELLINGTON | reporter.nih.gov |
| Impact of maternal marijuana use on epigenetic regulation of offspring neurodevelopment | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,100,000 | September 15, 2022 | August 31, 2027 | LO, JAMIE | reporter.nih.gov |
| Brain and behavior correlates of prenatal cannabis exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,095,376 | July 15, 2023 | May 31, 2028 | KLEINHANS, NATALIA M | reporter.nih.gov |
| High-Throughput NMJ Assay for Botox Potency Screening | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $2,086,960 | August 1, 2023 | January 31, 2027 | GEISSE, NICHOLAS ANDREW | reporter.nih.gov |
| Modeling CNS dynamics in HIV infection and cannabinoids with forebrain organoids | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,085,642 | August 1, 2019 | June 30, 2025 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Prenatal alcohol/cannabinoid co-exposures and fetal brain development | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $2,076,761 | May 1, 2020 | April 30, 2026 | MIRANDA, RAJESH C | reporter.nih.gov |
| Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study | NIH | National Institute on Aging | 2025 | $2,072,617 | August 15, 2025 | July 31, 2028 | MINTZER, JACOBO | reporter.nih.gov |
| Mapping and Understanding Production of Natural Products in Fungi | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,063,341 | April 1, 2016 | May 31, 2027 | KELLEHER, NEIL L | reporter.nih.gov |
| Pharmacophore - Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,056,227 | January 1, 2020 | December 31, 2029 | ROMO, DANIEL | reporter.nih.gov |
| SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $2,054,674 | September 1, 2021 | August 31, 2024 | KORMAN, TYLER P | reporter.nih.gov |
| Effects of High Potency Cannabis Products on Mental Health and Psychosocial Functioning | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,053,256 | May 15, 2023 | March 31, 2028 | HOPFER, CHRISTIAN J | reporter.nih.gov |
| Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $2,051,325 | September 20, 2023 | July 31, 2025 | KIMLESS, DEBRA | reporter.nih.gov |
| Preclinical Assessment of Medications for Alcohol Abuse | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $2,042,668 | September 28, 2007 | March 31, 2025 | WEERTS, ELISE M | reporter.nih.gov |
| Synthetic biology tools for scalable production of medicinal plant terpenes | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $2,036,524 | September 15, 2019 | June 30, 2025 | SATTELY, ELIZABETH SUSAN | reporter.nih.gov |
| Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,030,405 | April 20, 2022 | March 31, 2027 | HUTCHISON, KENT E. | reporter.nih.gov |
| Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline | NIH | National Cancer Institute | 2023 to 2025 | $2,026,604 | September 1, 2023 | August 31, 2028 | SEDRAK, MINA S | reporter.nih.gov |
| A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment | NIH | National Institute on Aging | 2024 to 2025 | $2,019,940 | December 1, 2023 | March 31, 2027 | BROWN, JEFFREY M. | reporter.nih.gov |
| Chemoenzymatic Synthesis, Mode of Action and Evolution of Natural Product-based Macrocycles | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,015,905 | September 5, 2017 | August 31, 2027 | BOWERS, ALBERT A | reporter.nih.gov |
| Effect of Microbial Metabolites on Growth of Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,012,133 | December 13, 2019 | November 30, 2024 | SIBLEY, L. DAVID | reporter.nih.gov |
| In vivo study of THC-induced immunogenome changes at single cell resolution in HIV-infected humans | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,010,652 | September 30, 2020 | June 30, 2027 | XU, KE | reporter.nih.gov |
| Mechanisms and Evolution of Assembly-Line Polyketide Synthases | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,008,493 | June 1, 2021 | May 31, 2026 | KHOSLA, CHAITAN | reporter.nih.gov |
| Novel approaches to assessing cannabis impaired driving | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,006,137 | July 1, 2020 | October 31, 2025 | BROOKS-RUSSELL, ASHLEY | reporter.nih.gov |
| BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERSTASK ORDER TITLE: FURTHER DEVELOPMENT OF MITOCHONDRIA-TARGETED HONOKIOL | NIH | National Cancer Institute | 2024 to 2025 | $2,002,559 | September 25, 2025 | March 24, 2028 | reporter.nih.gov | |
| Assigning mode of action to phenotypically discovered anticancer leads. | NIH | National Cancer Institute | 2023 to 2024 | $2,000,000 | September 21, 2023 | July 31, 2025 | MAKAROV, SERGEI S | reporter.nih.gov |
| Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $2,000,000 | April 24, 2024 | March 31, 2026 | KRONAUGE, JAMES F | reporter.nih.gov |
| New oral antibiotics focused on treating MDR Gram-negative infections | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,000,000 | July 9, 2024 | June 30, 2027 | TESTA, CHARLES | reporter.nih.gov |
| A new class of antibiotic to address Antimicrobial Resistance | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,999,995 | May 1, 2024 | April 30, 2027 | TESTA, CHARLES | reporter.nih.gov |
| A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $1,999,908 | May 16, 2024 | April 30, 2026 | KAMBOURAKIS, SPIROS | reporter.nih.gov |
| Ceraxa (Ceramide NanoLiposome) and Vinblastine For the Improved Treatment of Relapsed or Refractory Acute Myeloid Leukemia | NIH | National Cancer Institute | 2022 to 2023 | $1,999,256 | September 14, 2022 | August 31, 2025 | ADAIR, BERNADETTE MCMAHON | reporter.nih.gov |
| Defining the impact of cannabinoids on the latent HIV reservoir through multi-omic analysis | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,995,250 | July 1, 2021 | May 31, 2024 | BROWNE, EDWARD P | reporter.nih.gov |
| Biomarkers of Dietary Flavonoid Intake, Carbonyl Stress, and Metabolic Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,983,942 | August 1, 2022 | May 31, 2027 | SANG, SHENGMIN | reporter.nih.gov |
| Influence of bacterial tryptophan metabolism on inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,982,751 | April 10, 2019 | July 31, 2029 | KUHN, KRISTINE A. | reporter.nih.gov |
| Novel Targeted Anticancer Agents from Marine Cyanobacteria | NIH | National Cancer Institute | 2021 to 2025 | $1,978,529 | March 6, 2013 | January 31, 2030 | LUESCH, HENDRIK | reporter.nih.gov |
| Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $1,972,182 | January 1, 2022 | December 31, 2026 | ZHANG, XINNA | reporter.nih.gov |
| Discovery and Biosynthesis of Bacterial Terpenoids | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,950,115 | August 1, 2021 | July 31, 2026 | RUDOLF, JEFFREY DANIEL | reporter.nih.gov |
| Tethered aza-Wacker Technology for Complex Antibiotic Assembly | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,930,783 | September 1, 2021 | July 31, 2027 | SATHYAMOORTHI, SHYAM | reporter.nih.gov |
| Synthesis, Structure, and Mechanism of Biorelevant Molecules and Reactions | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,930,646 | April 1, 2018 | July 31, 2028 | HOYE, THOMAS R. | reporter.nih.gov |
| Indole dysbiosis and mucosal inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,930,131 | June 1, 2012 | December 31, 2028 | COLGAN, SEAN P | reporter.nih.gov |
| Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics | NIH | National Cancer Institute | 2023 to 2025 | $1,930,054 | September 21, 2023 | August 31, 2028 | REBOUSSIN, BETH A. | reporter.nih.gov |
| Accessing and expanding microbial bioactive chemical diversity by synthetic biology and new enzymology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,927,447 | July 1, 2018 | June 30, 2028 | DING, YOUSONG | reporter.nih.gov |
| Discovery and Characterization of Natural Product Systems | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,917,817 | June 1, 2016 | May 31, 2026 | SHERMAN, DAVID H | reporter.nih.gov |
| Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC | NIH | National Cancer Institute | 2023 to 2025 | $1,915,200 | August 1, 2023 | July 31, 2028 | BRYAN, ANGELA | reporter.nih.gov |
| Machine learning approaches for the discovery, repurposing, and optimization of natural products with therapeutic potential | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,912,959 | September 1, 2022 | August 31, 2027 | WALKER, ALLISON SARA | reporter.nih.gov |
| Biochemistry and Pharmacology of the Macular Carotenoids | NIH | National Eye Institute | 2021 to 2025 | $1,908,354 | August 1, 1997 | April 30, 2027 | BERNSTEIN, PAUL STEVEN | reporter.nih.gov |
| Covalent Inhibition as a Method to Counteract Botulinum Intoxication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,905,848 | June 2, 2020 | November 30, 2024 | JANDA, KIM | reporter.nih.gov |
| Synthesis and Evaluation of Alkaloids to Probe Membrane Receptors | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,905,708 | August 1, 2022 | June 30, 2027 | RILEY, ANDREW | reporter.nih.gov |
| Quercetin prevent airway epithelial remodeling and promote lung health in OPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,898,463 | July 1, 2021 | June 30, 2025 | SAJJAN, UMADEVI SIVANAPPA | reporter.nih.gov |
| Heme-Dependent Chemistry in Aromatic Oxidation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,887,949 | August 1, 2014 | August 31, 2026 | LIU, AIMIN | reporter.nih.gov |
| Development of an intravenous CB1 antagonist for acute cannabinoid intoxication and cannabis hyperemesis syndrome | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,886,590 | August 1, 2024 | July 31, 2026 | CUNDY, KENNETH | reporter.nih.gov |
| Halogenation Biochemistry in Human and Environmental Health | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,868,760 | July 1, 2021 | April 30, 2027 | AGARWAL, VINAYAK | reporter.nih.gov |
| Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $1,867,660 | March 17, 2023 | February 28, 2028 | PIOVEZAN FUGOLIN, ANA PAULA | reporter.nih.gov |
| Novel neuroprotective activities of flavonoids against retinal degenerative diseases | NIH | National Eye Institute | 2022 to 2025 | $1,867,600 | September 30, 2022 | May 31, 2026 | JASTRZEBSKA, BEATA | reporter.nih.gov |
| Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,866,314 | September 30, 2023 | July 31, 2028 | D'SOUZA, DEEPAK CYRIL | reporter.nih.gov |
| Aging-associated mammary cancer-initiating cells | NIH | National Cancer Institute | 2021 to 2025 | $1,860,500 | September 17, 2021 | August 31, 2026 | SUN, LUZHE | reporter.nih.gov |
| Validation of biomarkers of infant and toddler carotenoid intake | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,852,489 | May 1, 2023 | April 30, 2028 | MORAN, NANCY E | reporter.nih.gov |
| Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,847,120 | July 1, 2020 | May 31, 2026 | LAKSHMANA, MADEPALLI KRISHNAPPA | reporter.nih.gov |
| Functional implications of stroke and Botulinum Neurotoxin on ankle stiffness and viscosity during gait | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,843,778 | May 1, 2023 | March 31, 2028 | ROUSE, ELLIOTT J | reporter.nih.gov |
| Evolution and consequences of multidrug resistant ribosome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,843,401 | September 16, 2020 | August 31, 2025 | YAP, M.-N. FRANCES | reporter.nih.gov |
| New Methods and Strategies for the Synthesis and Selective Derivatization of Natural Products | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,840,796 | May 2, 2020 | March 31, 2030 | NAGORNY, PAVEL | reporter.nih.gov |
| HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,839,474 | March 15, 1992 | February 28, 2026 | THAYER, STANLEY A | reporter.nih.gov |
| Structure and Function of Biosynthetic Enzymes | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,838,353 | August 1, 1998 | August 31, 2026 | CHRISTIANSON, DAVID W | reporter.nih.gov |
| Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer. | NIH | National Cancer Institute | 2021 to 2025 | $1,832,774 | May 1, 2021 | April 30, 2026 | MCGAHA, TRACY L | reporter.nih.gov |
| Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastoma | NIH | National Cancer Institute | 2021 to 2024 | $1,825,419 | September 15, 2020 | June 30, 2026 | SONABEND, ADAM M | reporter.nih.gov |
| Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,820,801 | June 21, 2024 | April 30, 2029 | MEHRA, SMRITI | reporter.nih.gov |
| Engineering Yeast towards High Titer Production of Monoterpene Indole Alkaloid Natural Products | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $1,819,978 | July 1, 2018 | March 31, 2028 | TANG, YI | reporter.nih.gov |
| IgE Suppressing Berberine Nanomedicine for Treatment of Food Allergies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,814,418 | May 11, 2023 | April 30, 2026 | YANG, NAN | reporter.nih.gov |
| Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,813,414 | January 1, 2020 | December 31, 2024 | HOFSETH, LORNE J | reporter.nih.gov |
| Guanidinium Toxins as Molecular Probes for NaV Study | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,805,820 | September 1, 2016 | March 31, 2026 | DU BOIS, JUSTIN | reporter.nih.gov |
| 600 MHz NMR spectrometer with 1.7mm micro-cryoprobe | NIH | Office of the Director, National Institutes of Health | 2023 | $1,802,603 | September 1, 2023 | August 31, 2025 | DUGGAN, BRENDAN MICHAEL | reporter.nih.gov |
| Lead optimization of a novel cyclic aryl-indole efflux pump inhibitor (EPI) series in combination with levofloxacin against Pseudomonas aeruginosa | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,799,789 | May 1, 2024 | April 30, 2027 | PARHI, AJIT K | reporter.nih.gov |
| Production of Natural Deoxysugars for Use in Chemical Synthesis of Glycosides | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $1,798,147 | March 17, 2022 | July 31, 2025 | TURNER, ROBERT J. | reporter.nih.gov |
| Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,796,578 | January 1, 2019 | April 30, 2027 | JOHNSON, JEREMY JAMES | reporter.nih.gov |
| Phase II Clinical trial of GTC in Men on Active Surveillance | NIH | National Cancer Institute | 2021 to 2024 | $1,792,639 | June 1, 2019 | May 31, 2026 | KUMAR, NAGI B. | reporter.nih.gov |
| Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,788,361 | January 1, 2019 | December 31, 2024 | SINGH, SHIVENDRA | reporter.nih.gov |
| Connecting specialized metabolism to social cues in actinomycete bacteria | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,787,304 | August 1, 2018 | May 31, 2028 | TRAXLER, MATTHEW F | reporter.nih.gov |
| Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,784,987 | May 1, 2022 | February 28, 2027 | LU, HUI-CHEN | reporter.nih.gov |
| Twist1 as a Target for Prevention and Treatment of Cutaneous Squamous Cell Carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $1,780,213 | July 1, 2021 | December 31, 2026 | DIGIOVANNI, JOHN | reporter.nih.gov |
| AI-based Mapping of Complex Cannabis Extracts in Pain Pathways | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,776,225 | February 14, 2023 | November 30, 2027 | VRANA, KENT E | reporter.nih.gov |
| Synthesis of Neurologically Active Small Molecules | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,773,111 | September 1, 2017 | May 31, 2027 | NEWHOUSE, TIMOTHY | reporter.nih.gov |
| Optical Redox Probe for Continuous Metabolic Monitoring during Natural Products Bioprocessing | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,772,804 | December 20, 2019 | July 31, 2025 | ZHAO, YOUBO | reporter.nih.gov |
| Therapeutic bubble tea: Preventing the formation of uremic toxins with hydrogel immobilized microbes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,772,161 | January 1, 2022 | December 31, 2026 | WINKLER, MARI-KAROLIINA | reporter.nih.gov |
| Enabling synthetic biology through single cell functional genomics | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,766,196 | February 1, 2022 | January 31, 2027 | BURKART, MICHAEL D. | reporter.nih.gov |
| Microbially guided discovery and biosynthesis of biologically active natural products | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,763,162 | July 1, 2021 | April 30, 2027 | FOX, JEROME | reporter.nih.gov |
| Synthesis and Study of Medicinally Important Molecules | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,762,112 | August 4, 2018 | July 31, 2028 | DAI, MINGJI | reporter.nih.gov |
| MegaTrans – human transporter machine learning models | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $1,729,534 | April 1, 2019 | August 31, 2025 | EKINS, SEAN | reporter.nih.gov |
| Structural Biology of Complex Enzymes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,723,943 | February 1, 1990 | May 31, 2026 | SMITH, JANET L. | reporter.nih.gov |
| Prevention of paclitaxel-induced peripheral neuropathy with nilotinib | NIH | National Cancer Institute | 2021 to 2023 | $1,723,403 | April 17, 2019 | March 31, 2025 | HU, SHUIYING | reporter.nih.gov |
| Botanical Approaches to Combat Metabolic Syndrome | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $1,722,093 | May 1, 2009 | April 30, 2026 | BRANTLEY, PHILLIP J | reporter.nih.gov |
| Cannabidiol and terpenoid interactions in amygdalar regulation of pain states | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $1,717,472 | May 1, 2022 | January 31, 2027 | LAND, BENJAMIN | reporter.nih.gov |
| Cannabidiol-enhanced cognitive behavioral therapy for generalized anxiety disorder | NIH | National Institute of Mental Health | 2025 | $1,715,387 | June 1, 2025 | May 31, 2027 | MARUSAK, HILARY | reporter.nih.gov |
| High throughput biosynthesis of ribosomally synthesized and post-translationally modified peptide natural products | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,714,719 | July 1, 2021 | May 31, 2027 | WALKER, MARK CHALFANT | reporter.nih.gov |
| Islet encapsulation to elicit localized immunosuppression and immune modulation following transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,713,109 | September 15, 2023 | July 31, 2028 | TSE, HUBERT M | reporter.nih.gov |
| Harnessing light and model endosymbiosis to produce natural products | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,709,070 | September 20, 2021 | June 30, 2027 | MEHTA, ANGAD | reporter.nih.gov |
| Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,704,831 | August 1, 2020 | June 30, 2025 | SWARTZ, TALIA H | reporter.nih.gov |
| Role of the Macrophage in Developmentally Programmed NAFLD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,703,451 | July 1, 2020 | June 30, 2025 | FRIEDMAN, JACOB E | reporter.nih.gov |
| Chemical Synthesis of Bioactive Diterpenoids | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,702,724 | September 1, 2022 | June 30, 2027 | VANDERWAL, CHRISTOPHER D | reporter.nih.gov |
| Antitumor Antibiotics | NIH | National Cancer Institute | 2021 to 2024 | $1,702,340 | February 1, 1986 | March 31, 2026 | BOGER, DALE L | reporter.nih.gov |
| Carotenoids in Vision | NIH | National Eye Institute | 2021 to 2024 | $1,698,273 | August 1, 2011 | April 30, 2026 | VON LINTIG, JOHANNES FRIEDRICH | reporter.nih.gov |
| Cannabis use and cardiovascular health outcomes among patients with high blood pressure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,692,524 | September 15, 2023 | July 31, 2028 | ALSHAARAWY, OMAYMA O | reporter.nih.gov |
| Neuro-immune mechanisms of minor cannabinoids in inflammatory and neuropathic pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $1,692,291 | September 15, 2019 | June 30, 2025 | HELLMAN, JUDITH | reporter.nih.gov |
| Combinatorial epigenetic-based prevention of breast cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,689,846 | April 1, 2014 | December 31, 2026 | TOLLEFSBOL, TRYGVE O | reporter.nih.gov |
| Impact of THC on Extracellular Vesicle Signaling | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,685,105 | June 15, 2020 | April 30, 2026 | FOWLER, CHRISTIE D | reporter.nih.gov |
| Intracellular Stress Inputs to SAPK Signaling Pathways | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,679,716 | September 30, 1992 | May 31, 2026 | LEVIN, DAVID E. | reporter.nih.gov |
| Glutamatergic plasticity that drives cannabinoid withdrawal and craving | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,674,683 | September 1, 2023 | July 31, 2028 | SPENCER, SADE MONIQUE | reporter.nih.gov |
| Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,661,440 | June 8, 2023 | February 28, 2027 | SHENVI, RYAN ASHOK | reporter.nih.gov |
| New Cooperative Catalysis Concepts for Asymmetric Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,661,400 | June 1, 2020 | May 31, 2025 | SCHEIDT, KARL A | reporter.nih.gov |
| A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $1,654,892 | September 25, 2021 | August 31, 2025 | PRINCE, ROBIN | reporter.nih.gov |
| Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,652,097 | September 1, 2019 | May 31, 2026 | BRYAN, ANGELA | reporter.nih.gov |
| Decoding and targeting saccharopine pathway in cancer metastasis | NIH | National Cancer Institute | 2022 to 2025 | $1,649,759 | February 1, 2022 | January 31, 2027 | KANG, SUMIN | reporter.nih.gov |
| Administrative supplement to promote diversity in health-related research: Melisa Gonzalez | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,649,257 | December 1, 2021 | November 30, 2026 | BUTCHER, REBECCA A | reporter.nih.gov |
| Controlled Release Eczema Bandage (CREB) | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $1,626,559 | August 1, 2025 | April 15, 2026 | SINGHAL, AJ | reporter.nih.gov |
| Symbiosis and Chemical Diversity Generation | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,620,154 | February 1, 2023 | January 31, 2028 | SCHMIDT, ERIC W | reporter.nih.gov |
| Senolytics To slOw Progression of Sepsis (STOP-Sepsis) trial | NIH | National Institute on Aging | 2022 to 2024 | $1,615,531 | July 15, 2022 | June 30, 2025 | PUSKARICH, MICHAEL A. | reporter.nih.gov |
| Unlocking the biomedical potential of microbial symbionts from complex ecosystems | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,613,534 | July 1, 2022 | April 30, 2027 | MEVERS, EMILY ELIZABETH | reporter.nih.gov |
| Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma | NIH | National Cancer Institute | 2022 to 2025 | $1,611,629 | August 1, 2022 | July 31, 2027 | VIVERO-ESCOTO, JUAN LUIS | reporter.nih.gov |
| Investigating (di)terpenoid biosynthesis | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,611,459 | June 1, 2019 | November 30, 2024 | PETERS, REUBEN JOHN | reporter.nih.gov |
| OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMA | NIH | National Cancer Institute | 2021 to 2023 | $1,608,570 | February 1, 2019 | January 31, 2025 | GRINSTAFF, MARK W. | reporter.nih.gov |
| Understanding How Nonheme Iron-Dependent Enzymes Assemble Pharmacophores: Studies of Cyclopropane, Aziridine, and Isonitrile Formation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,604,936 | June 1, 2018 | June 30, 2028 | CHANG, WEI-CHEN | reporter.nih.gov |
| Hearing Protection in Cisplatin Chemotherapy | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $1,600,000 | February 1, 2022 | January 31, 2027 | TAN, XIAODONG | reporter.nih.gov |
| Biosynthesis and Enzymology of Antifungal Natural Products | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,593,275 | November 15, 2018 | October 31, 2024 | TANG, YI | reporter.nih.gov |
| MUFA-SIRT1 signaling as a central node regulating healthspan | NIH | National Institute on Aging | 2021 to 2024 | $1,588,424 | September 15, 2020 | May 31, 2025 | MASHEK, DOUGLAS G | reporter.nih.gov |
| Molecular effects of cannabinoids on the Blood Brain Barrier in HIV-infected brain | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,588,360 | August 15, 2024 | May 31, 2029 | MARCONDES, MARIA CECILIA GARIBALDI | reporter.nih.gov |
| Determining the Architectures and Activities of Polyketide Synthase Modules | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,582,712 | July 1, 2013 | April 30, 2027 | KEATINGE-CLAY, ADRIAN TRISTAN | reporter.nih.gov |
| Structural Studies of Nonribosomal Peptide Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,582,452 | April 1, 2020 | March 31, 2026 | GULICK, ANDREW M | reporter.nih.gov |
| Investigating mechanisms mediating enhanced THC reinforcement by nicotine | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,579,328 | July 1, 2023 | May 31, 2028 | TORREGROSSA, MARY M | reporter.nih.gov |
| Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,575,153 | June 12, 2020 | May 31, 2026 | O'CONNOR, ROBERTA M | reporter.nih.gov |
| Synthetic Macrophage-inducible C-type lectin (Mincle) Agonists: Screening, Design, and Formulation in combination Th17 adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $1,563,776 | September 30, 2024 | September 29, 2029 | reporter.nih.gov | |
| Biosynthesis of marine terpenoid natural products | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,561,415 | August 1, 2023 | May 31, 2027 | MOORE, BRADLEY S | reporter.nih.gov |
| Therapeutic and Mechanistic Evaluation of Cannabis sativa Terpenes in Neuropathic Pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $1,560,823 | July 1, 2021 | April 30, 2027 | STREICHER, JOHN MICHAEL | reporter.nih.gov |
| Cannabinoid modulation of EV composition and function in HIV/SIV infection | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,560,682 | August 1, 2022 | July 31, 2025 | OKEOMA, CHIOMA M | reporter.nih.gov |
| Natural Product Genome Mining | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,554,961 | August 1, 2009 | July 31, 2025 | MOORE, BRADLEY S | reporter.nih.gov |
| CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,551,552 | April 15, 2019 | February 28, 2026 | HOHMANN, ANDREA GRACE | reporter.nih.gov |
| Methylotrophs: underexplored bacteria for discovering novel natural products and biochemistry | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,548,728 | July 1, 2022 | June 30, 2027 | PURI, AARON WEBSTER | reporter.nih.gov |
| Chemoproteomic mapping of the ligandable ribonucleoproteome using phloroglucinol meroterpenoids | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,543,181 | July 1, 2021 | December 31, 2024 | ABBASOV, MIKAIL E | reporter.nih.gov |
| Discovery and characterization of biocatalysts and metabolites for ribosomally encoded alpha-N-methylated peptide natural products | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,541,928 | August 1, 2019 | April 30, 2030 | FREEMAN, MICHAEL F | reporter.nih.gov |
| Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,527,736 | September 30, 2020 | August 31, 2026 | MEADE, CHRISTINA S | reporter.nih.gov |
| Therapeutic small molecule modulation of Kv channels | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,525,426 | April 1, 2019 | July 31, 2030 | ABBOTT, GEOFFREY W | reporter.nih.gov |
| Mechanistic studies of hirsutinolides and azetidine-based small molecule inhibitors of STAT3 | NIH | National Cancer Institute | 2024 to 2025 | $1,519,343 | April 1, 2024 | March 31, 2029 | TURKSON, JAMES K | reporter.nih.gov |
| Polyketides via Redox-Triggered Alcohol C-H Functionalization | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,515,454 | May 1, 2011 | May 31, 2025 | KRISCHE, MICHAEL J | reporter.nih.gov |
| Vibrio microcins. A hidden field of targeted anti-cholerae natural products. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,511,046 | June 1, 2024 | April 30, 2029 | DAVIES, BRYAN WILLIAM | reporter.nih.gov |
| Novel Dearomative Indole Annulation Reactions, Beckmann Fragmentations, and Their Applications to Synthesis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,502,537 | September 1, 2022 | July 31, 2026 | WU, JIMMY | reporter.nih.gov |
| Posttranslational Modifications during Natural Product Biosynthesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,500,616 | February 1, 1999 | May 31, 2026 | VAN DER DONK, WILFRED A. | reporter.nih.gov |
| Electrochemically-Controlled Rapid Chromatographic Separation of Nuisance Compounds from Natural Product Extracts | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,498,000 | September 19, 2022 | August 31, 2024 | SITHARAMAN, BALAJI | reporter.nih.gov |
| New Photocatalytic Coupling Reactions to Prepare Bioactive Molecules | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,497,816 | August 1, 2020 | November 30, 2025 | MARTIN, DAVID | reporter.nih.gov |
| Novel antifungal agents against coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,496,572 | July 17, 2024 | May 31, 2029 | WALCZAK, MACIEJ | reporter.nih.gov |
| Synthesis of Partially Saturated Nitrogen Heterocycles Through Stereo- And Regioselective Dearomatization of Heteroarenes | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,496,033 | August 15, 2022 | June 30, 2027 | KARIMOV, RASHAD RISHAD | reporter.nih.gov |
| Identification, characterization, and application of bacterial site-specific vanadium-dependent haloperoxidase enzymes | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,491,048 | August 1, 2022 | May 31, 2027 | MCKINNIE, SHAUN MITCHELL KIRK | reporter.nih.gov |
| Chemical Synthesis and Biology of Complex Alkaloids | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,490,085 | April 1, 2020 | March 31, 2024 | MAIMONE, THOMAS JOHN | reporter.nih.gov |
| New Methods for the Synthesis of Biologically Active Compounds | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,489,963 | June 1, 2023 | March 31, 2028 | WOERPEL, KEITH ALLEN | reporter.nih.gov |
| Biosensor-driven Platforms for Biosynthesis of Natural Products in Bacteria | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,487,976 | September 1, 2018 | November 30, 2028 | YAN, YAJUN | reporter.nih.gov |
| Identification of Natural Compound Combinations for Prevention of Prostate Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,485,787 | February 1, 2019 | January 31, 2025 | DIGIOVANNI, JOHN | reporter.nih.gov |
| Bioinformatic Guided Discovery and Characterization of New RiPP Natural Products | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,482,563 | August 1, 2022 | May 31, 2027 | CHEKAN, JONATHAN RODI | reporter.nih.gov |
| Define the effects and mechanism of THC and CBD on IFN-I mediated inflammation and immune dysfunction during HIV infection | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,482,000 | September 30, 2020 | July 31, 2025 | ZHEN, ANJIE | reporter.nih.gov |
| Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments | NIH | National Cancer Institute | 2023 to 2025 | $1,471,480 | September 20, 2023 | August 31, 2029 | HU, JENNIFER J | reporter.nih.gov |
| Catalytic Processes for Stereoselective Radical Cyclization Reactions | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,464,433 | September 1, 2015 | August 31, 2027 | ZHANG, X. PETER | reporter.nih.gov |
| Control of Facial Amphiphilicity to Tune Macromolecular Interactions with Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,460,600 | December 1, 2019 | July 31, 2025 | TANG, CHUANBING | reporter.nih.gov |
| Defining the impact of cannabinoids on the latent HIV reservoir through multi-omic analysis | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,460,156 | July 1, 2021 | June 30, 2027 | BROWNE, EDWARD P | reporter.nih.gov |
| Mechanisms of novel biological nitrogen chemistries | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,458,552 | August 1, 2022 | July 31, 2027 | CARANTO, JONATHAN D | reporter.nih.gov |
| Discovery and characterization of a novel natural product for the treatment of both diabetes and obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,457,887 | September 1, 2023 | June 30, 2027 | LIU, DONGMIN | reporter.nih.gov |
| Discovery, Biosynthesis and Engineering of Side-Chain-Macrocyclic Plant Peptides | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,451,177 | July 1, 2022 | April 30, 2027 | KERSTEN, ROLAND DAVID | reporter.nih.gov |
| A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,442,826 | January 1, 2022 | December 31, 2026 | SINGH, SHANTERI | reporter.nih.gov |
| Phosphine-Catalyzed Annulations and their Applications | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,430,462 | May 1, 2006 | June 30, 2027 | KWON, OHYUN | reporter.nih.gov |
| Novel nutriceuticals relax airway smooth muscle and decrease inflammation in allergic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,425,021 | December 1, 2019 | November 30, 2024 | EMALA, CHARLES W | reporter.nih.gov |
| Targeting autophagy to reduce inflammasome-mediated inflammation and immune dysfunction in HIV and methamphetamine use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,416,081 | June 1, 2024 | March 31, 2029 | ZHEN, ANJIE | reporter.nih.gov |
| International Research Training Center for Botanicals and Chronic Diseases in Indonesia, Ecuador and Tajikistan | NIH | Fogarty International Center | 2021 to 2025 | $1,414,949 | July 28, 2014 | May 31, 2030 | RASKIN, ILYA | reporter.nih.gov |
| Risk and resilience pathways linking community adversity, decision making, and alcohol misuse: A prospective study of Appalachian adolescents | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,412,134 | September 10, 2019 | June 30, 2025 | KRISTJANSSON, ALFGEIR | reporter.nih.gov |
| Examining Gut Microbiome as a Determinant of Blueberry Polyphenol Bioavailability to Optimize Dose and Phytochemical Standardization for Functional Effects in Humans | NIH | National Center for Complementary & Integrative Health | 2025 | $1,407,811 | September 1, 2025 | August 31, 2030 | WEIR, TIFFANY L | reporter.nih.gov |
| Atom-swapping reaction sequences enabled by decarbonylation and decarboxylation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,405,931 | July 5, 2022 | May 31, 2027 | LI, JUNQI | reporter.nih.gov |
| Understanding the specificity and non-native catalytic activity of PLP-dependent enzymes | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,405,308 | August 1, 2023 | May 31, 2028 | HAI, YANG | reporter.nih.gov |
| Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,398,086 | February 15, 2020 | January 31, 2026 | SRINIVASAN, RAHUL | reporter.nih.gov |
| Studies in the Synthesis of Complex Organic Molecules with Donor-Donor Carbenes | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,397,125 | September 1, 2023 | March 31, 2026 | SHAW, JARED THOMAS | reporter.nih.gov |
| 3D Printed Calcium Phosphate Scaffolds with Natural Medicinal Compounds for Dental Applications | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,391,424 | August 1, 2020 | July 31, 2026 | BOSE, SUSMITA | reporter.nih.gov |
| Alkaloid Biosynthetic Studies | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,390,322 | August 1, 2021 | June 30, 2025 | LIU, PINGHUA | reporter.nih.gov |
| Integrative Model of Metabolomics, Equol and Atherosclerotic cardiovascular disease (IMMEA) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,385,831 | September 1, 2024 | May 31, 2028 | SEKIKAWA, AKIRA | reporter.nih.gov |
| Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol use among PWH in Nairobi, Kenya | NIH | National Cancer Institute | 2024 to 2025 | $1,382,393 | September 18, 2024 | August 31, 2029 | HIMELHOCH, SETH S | reporter.nih.gov |
| Discovery and development of drug cocktails evolved by Nature | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,379,650 | July 1, 2022 | April 30, 2027 | ZHU, XUEJUN | reporter.nih.gov |
| Iterative Polyketide Synthase Function, Structure and Pathways | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,374,999 | February 1, 1978 | December 31, 2025 | TOWNSEND, CRAIG ARTHUR | reporter.nih.gov |
| Biosynthesis and biological mechanism of minor cannabinoids | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $1,373,136 | December 20, 2023 | October 31, 2028 | MOORE, BRADLEY S | reporter.nih.gov |
| Genomics-Accelerated Discovery and Biosynthesis of Phosphonic Acid Natural Products | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,369,457 | September 15, 2020 | July 31, 2025 | JU, KOU-SAN | reporter.nih.gov |
| EXCITED-STATE CATALYSIS IN ORGANIC SYNTHESIS | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,362,969 | August 5, 2016 | May 31, 2026 | NGAI, MING-YU | reporter.nih.gov |
| Advancing the basic science of membrane permeability in macrocyclic peptides | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,353,856 | January 1, 2023 | December 31, 2027 | LOKEY, ROBERT SCOTT | reporter.nih.gov |
| Deconstructive Molecular Editing Technology Involving C-C Bond Scission | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,353,593 | April 1, 2021 | December 31, 2024 | KWON, OHYUN | reporter.nih.gov |
| Novel Mechanisms of Catalysis in Natural Product Biosynthesis | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,353,592 | June 1, 2024 | May 31, 2029 | LIU, HUNG-WEN | reporter.nih.gov |
| Clinical Trial of Maternal Choline Supplements to Mitigate Effects of Prenatal Cannabis Exposure on Early Brain Development. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,348,364 | May 1, 2024 | February 28, 2029 | HUNTER, SHARON K | reporter.nih.gov |
| Selective Catalytic Strategies for Carbohydrate Synthesis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,344,888 | April 1, 2022 | January 31, 2026 | WENDLANDT, ALISON | reporter.nih.gov |
| Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,341,614 | August 15, 2022 | May 31, 2028 | HANEY, MARGARET | reporter.nih.gov |
| Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,337,048 | May 1, 2024 | February 28, 2029 | LEE, DUSTIN CLARK | reporter.nih.gov |
| Health effects of cannabidiol vaping products | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,323,987 | March 1, 2024 | December 31, 2027 | REBULI, MEGHAN ELIZABETH | reporter.nih.gov |
| Equipment Supplement: Methods and Strategies for the Concise Synthesis of Complex Alkaloid Natural Products | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,317,729 | September 10, 2021 | August 31, 2025 | RAWAL, VIRESH H. | reporter.nih.gov |
| Natural Products Research Training in Complementary and Integrative Health | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $1,315,994 | December 1, 2019 | November 30, 2029 | VAN BREEMEN, RICHARD B | reporter.nih.gov |
| Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation | NIH | National Institute on Aging | 2023 to 2025 | $1,315,608 | March 15, 2023 | December 31, 2027 | LESNIEWSKI, LISA A | reporter.nih.gov |
| Psychopharmacological effects of cannabidiol on responses to stress and nicotine withdrawal | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,303,839 | September 30, 2010 | February 28, 2029 | AL'ABSI, MUSTAFA | reporter.nih.gov |
| Phytotherapy for Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,299,643 | September 1, 2022 | May 31, 2027 | AROSH, JOE A. | reporter.nih.gov |
| Defining the complex genetic basis of Plasmodium falciparum resistance to artemisinin and quinine and identifying resistance-refractory therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,297,430 | May 17, 2024 | March 31, 2029 | FIDOCK, DAVID A | reporter.nih.gov |
| Mechanisms underlying reversal of cardiac aging by urolithin a treatment | NIH | National Institute on Aging | 2024 to 2025 | $1,282,390 | September 15, 2024 | August 31, 2029 | MARCINEK, DAVID J. | reporter.nih.gov |
| Harnessing Polyketide Assembly Lines for Medicinal Chemistry | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,272,120 | July 1, 2022 | May 31, 2027 | KEATINGE-CLAY, ADRIAN TRISTAN | reporter.nih.gov |
| Gut Microbiota Underlies the Heterogeneity of Aging Brain's Susceptibility to Postoperative Delirium | NIH | National Institute on Aging | 2024 to 2025 | $1,271,798 | August 1, 2021 | July 31, 2027 | SHEN, SHIQIAN | reporter.nih.gov |
| Epigallocatechin gallate for prevention of lethal cirrhosis complications | NIH | National Cancer Institute | 2023 to 2024 | $1,270,168 | September 6, 2023 | August 31, 2028 | HOSHIDA, YUJIN | reporter.nih.gov |
| Resource Center for Cannabis and Cannabinoid Research (R3CR) | NIH | National Center for Complementary & Integrative Health | 2025 | $1,260,872 | April 1, 2025 | March 31, 2030 | KHAN, IKHLAS AHMAD | reporter.nih.gov |
| Mechanisms of Novel Herbal Therapies for Sepsis. | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $1,256,250 | September 1, 2010 | June 30, 2025 | WANG, HAICHAO | reporter.nih.gov |
| Discovery and characterization of synthetic bioinformatic natural product anticancer agents | NIH | National Cancer Institute | 2023 to 2025 | $1,248,263 | May 1, 2023 | April 30, 2028 | BRADY, SEAN F | reporter.nih.gov |
| A Divergent Platform to Chemically Redesign Bioactive 5-8-5 Terpenoids | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,245,359 | September 15, 2017 | December 31, 2026 | FREDERICH, JAMES H. | reporter.nih.gov |
| Accessing the hidden biosynthetic capabilities of fungi | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,244,288 | December 15, 2014 | April 30, 2025 | KELLER, NANCY P | reporter.nih.gov |
| Impact of Senolytics on Aged Vaccine Responses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,244,166 | November 1, 2022 | October 31, 2027 | BARTLEY, JENNA | reporter.nih.gov |
| Mechanisms of Biosynthetic Formation of Deoxy Sugars | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,243,033 | January 1, 1986 | May 31, 2025 | LIU, HUNG-WEN | reporter.nih.gov |
| Exploring a New Dimension of Microbial Secondary Metabolism | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,237,932 | July 5, 2021 | May 31, 2025 | SEYEDSAYAMDOST, MOHAMMAD R | reporter.nih.gov |
| Cellular Senescence in Trisomy 21 lung disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,236,223 | September 1, 2024 | June 30, 2028 | AL ALAM, DENISE | reporter.nih.gov |
| Research Training in Natural Product Complementary and Integrative Health | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $1,235,148 | January 1, 2013 | July 31, 2029 | PAULI, GUIDO F | reporter.nih.gov |
| Investigating neofunctionalized alpha-carbonic anhydrases as an emerging class of biosynthetic enzyme in plant and animal metabolism | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,233,380 | July 1, 2023 | April 30, 2028 | NETT, RYAN STEPHAN | reporter.nih.gov |
| Discovery and Engineering of Plant Natural Product Pathways | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,223,671 | August 1, 2017 | November 30, 2025 | SATTELY, ELIZABETH SUSAN | reporter.nih.gov |
| Cold triggered Local Anesthesia for Pain Management | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,223,651 | September 1, 2022 | November 21, 2025 | ZHAO, CHAO | reporter.nih.gov |
| Genomics Accelerated Natural Product Discovery | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,220,277 | September 15, 2017 | December 31, 2024 | MITCHELL, DOUGLAS ALAN | reporter.nih.gov |
| Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,219,744 | April 1, 2019 | September 30, 2024 | MCPHAIL, KERRY LEIGH | reporter.nih.gov |
| Synthesis of Complex Terpenes From Simple Precursors: Renewal | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,209,973 | April 1, 2016 | March 31, 2025 | MAIMONE, THOMAS JOHN | reporter.nih.gov |
| Chemical and Molecular Tools for Modulating GPCR Function | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,208,259 | June 1, 2023 | May 31, 2028 | OLSON, DAVID E | reporter.nih.gov |
| Plant terpenoids: Deciphering metabolic pathways and improving production in microbes | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,198,795 | September 1, 2023 | June 30, 2028 | WANG, ZHEN | reporter.nih.gov |
| Analgesic efficacy of single and combined minor cannabinoids and terpenes | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $1,188,750 | September 15, 2019 | June 30, 2025 | WARD, SARA J | reporter.nih.gov |
| Enabling Plant Natural Product Biosynthesis by Debugging Heterologous Protein Expression in Yeast | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,187,225 | August 1, 2019 | May 31, 2025 | BLENNER, MARK ALAN | reporter.nih.gov |
| Directed Evolution of Isoprenoid Biosynthesis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,183,677 | August 1, 2021 | May 31, 2026 | WILLIAMS, GAVIN J | reporter.nih.gov |
| Randomized placebo controlled trial to determine the biological signature of cannabidiol as a treatment for social anxiety disorder | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,180,991 | September 19, 2022 | February 28, 2026 | SIMON, NAOMI M | reporter.nih.gov |
| Targeting Senescence Specific Mechanisms of NF-κB Activation to Reverse Chronic Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,178,040 | May 1, 2024 | February 28, 2029 | HAAK, ANDREW JON | reporter.nih.gov |
| Biosynthesis of antifungal nucleoside antibiotics | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,176,963 | July 1, 2015 | August 31, 2024 | YOKOYAMA, KENICHI | reporter.nih.gov |
| Development of Strategies for the Enantioselective Synthesis of Heterocycles and Acyclic Amines | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,171,481 | July 1, 2022 | April 30, 2026 | APONICK, AARON | reporter.nih.gov |
| Biosynthesis of unusual bio-orthogonal functionalities in natural products | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,164,036 | July 1, 2020 | June 30, 2025 | ZHANG, WENJUN | reporter.nih.gov |
| Antitumor Agents: Structure and Synthesis | NIH | National Cancer Institute | 2021 to 2024 | $1,163,899 | June 30, 1976 | January 31, 2025 | SMITH, AMOS B | reporter.nih.gov |
| Mechanistic Studies of Lantibiotic Biosynthetic and Tailoring Enzymes | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,161,927 | February 1, 2006 | June 30, 2024 | NAIR, SATISH K | reporter.nih.gov |
| Development and Exploitation of New Synthetic Strategies for Tropolones | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,155,911 | May 1, 2015 | April 30, 2025 | MURELLI, RYAN | reporter.nih.gov |
| Botanical derived progestins and their impact on women's health | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,151,280 | May 1, 2016 | February 29, 2028 | BURDETTE, JOANNA E | reporter.nih.gov |
| Mechanism of botulinum neurotoxin transport across membranes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,147,915 | June 1, 2019 | May 31, 2025 | BALDWIN, MICHAEL R | reporter.nih.gov |
| microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,145,822 | August 16, 2019 | June 30, 2025 | ZHAI, RONG GRACE | reporter.nih.gov |
| Optical Control of the Actin Cytoskeleton | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,145,446 | August 1, 2018 | August 31, 2027 | TRAUNER, DIRK HARTWIG | reporter.nih.gov |
| Mechanisms of alcohol and menthol dependent pharmaco-neurological interactions with arecoline, an addictive and toxic areca (betel) nut xenobiotic | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,138,715 | July 1, 2023 | May 31, 2028 | MYERS, ALAN L | reporter.nih.gov |
| Herbal and Dietary Supplement Induced Liver Injury in the U.S. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,136,701 | September 30, 2008 | July 31, 2028 | HALEGOUA-DEMARZIO, DINA | reporter.nih.gov |
| Resolving the intoxication mechanism of botulinum neurotoxins using single molecule structural biology | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,134,828 | September 20, 2023 | June 30, 2027 | BOWEN, MARK E | reporter.nih.gov |
| Impact of quercetin on inflammatory and oxidative stress markers in COPD | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $1,133,111 | September 9, 2022 | May 31, 2026 | SAJJAN, UMADEVI SIVANAPPA | reporter.nih.gov |
| Attacking the Global Problem of Antimicrobial Resistance | NIH | National Eye Institute | 2021 to 2023 | $1,131,900 | January 1, 2005 | August 31, 2024 | HAZLETT, LINDA D | reporter.nih.gov |
| Molecular analysis of bacterial interactions | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,121,256 | July 1, 2023 | April 30, 2028 | GARG, NEHA | reporter.nih.gov |
| Dearomative Functionalization with Arenophiles | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,116,438 | July 15, 2017 | June 30, 2026 | SARLAH, DAVID | reporter.nih.gov |
| Age-related Cognitive Changes: Effects of Combined Flavonoid Intake and Physical Exertion Mediated by the Gut Microbiome | NIH | National Institute on Aging | 2024 to 2025 | $1,109,703 | September 1, 2024 | April 30, 2030 | LILA, MARY ANN ANN | reporter.nih.gov |
| Development of a Bacterial Host for Natural Product Discovery and Production | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,108,817 | September 20, 2020 | June 30, 2025 | EUSTAQUIO, ALESSANDRA S | reporter.nih.gov |
| Discovery, biosynthesis and bioactivity of phosphonic acid natural products | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,103,591 | April 1, 2018 | August 31, 2025 | METCALF, WILLIAM W | reporter.nih.gov |
| Supplement to Advancing CRISPR-Cas Technologies for the Discovery and Characterization of Novel Fungal Natural Products | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,103,196 | August 1, 2020 | March 31, 2024 | GAO, XUE | reporter.nih.gov |
| Lewis Base Ligands Designed to Control Carbon-Carbon Bond Formation | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,102,807 | August 1, 2023 | July 31, 2028 | THOMAS, ANDY ALEXANDER | reporter.nih.gov |
| Synthesis of Bioactive Natural Products and Unnatural Congeners | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,100,985 | August 1, 2023 | May 31, 2028 | SMITH, JOEL MICHAEL | reporter.nih.gov |
| Endocannabinoid System Engagement and Clinical Symptom Change with Cannabidiol for Social Anxiety Disorder | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,099,216 | January 18, 2022 | April 30, 2025 | TAYLOR, CHARLES | reporter.nih.gov |
| The biosynthesis of N-N bond-containing natural products | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,093,330 | January 1, 2020 | November 30, 2024 | BALSKUS, EMILY PATRICIA | reporter.nih.gov |
| Investigation of Unusual Cyclization Reactions in Biocatalysis | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,092,447 | April 1, 1989 | June 30, 2025 | LIU, HUNG-WEN | reporter.nih.gov |
| Mechanisms of paclitaxel sensitivity and resistance | NIH | National Cancer Institute | 2024 to 2025 | $1,089,160 | March 4, 2024 | February 28, 2029 | WEAVER, BETH A | reporter.nih.gov |
| Targeting microtubule stabilization to reduce breast tumor metastasis | NIH | National Cancer Institute | 2021 to 2023 | $1,086,136 | September 6, 2012 | June 30, 2024 | MARTIN, STUART S | reporter.nih.gov |
| Signaling mediators of CCL2/CCR2 and natural product discovery | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,083,333 | May 1, 2023 | April 30, 2028 | WANG, PIWEN | reporter.nih.gov |
| CXCR4 as a target for colon cancer chemoprevention | NIH | National Cancer Institute | 2021 to 2023 | $1,083,245 | July 1, 2019 | June 30, 2024 | BISSONNETTE, BRUCE MARC | reporter.nih.gov |
| Investigating biosynthetic enzymes to enhance natural product discovery | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,082,531 | August 5, 2023 | May 31, 2028 | HIGGINS, MELANIE ANN | reporter.nih.gov |
| CCAR2 as a Target for Prevention of Colorectal Cancer. | NIH | National Cancer Institute | 2021 to 2023 | $1,080,815 | April 1, 2008 | February 28, 2025 | DASHWOOD, RODERICK H | reporter.nih.gov |
| Enzyme Chemistry and Biological Function of RiPP-like Modifications | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,076,415 | February 1, 2012 | December 31, 2024 | MITCHELL, DOUGLAS ALAN | reporter.nih.gov |
| Salivary Protein Influence on Taste and Feeding | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $1,076,004 | January 1, 2019 | December 31, 2024 | TORREGROSSA, ANN-MARIE | reporter.nih.gov |
| Discovery and Application of New Halogenases | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,066,740 | April 1, 2020 | March 31, 2025 | CHANG, MICHELLE C | reporter.nih.gov |
| Carbon isotope exchange mediated by vanadium complexes | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,065,309 | August 1, 2023 | July 31, 2028 | BUKHRYAKOV, KONSTANTIN | reporter.nih.gov |
| The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180 | NIH | National Cancer Institute | 2021 to 2023 | $1,059,662 | April 1, 2019 | March 31, 2025 | SINGH, SHIVENDRA | reporter.nih.gov |
| Defining the impact of cannabinoids on the HIV reservoir in humanized mice | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,053,744 | September 30, 2023 | July 31, 2025 | BROWNE, EDWARD P | reporter.nih.gov |
| Therapeutics to prevent aminoglycoside-induced hearing loss | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $1,048,600 | July 17, 2020 | July 31, 2027 | ZUO, JIAN | reporter.nih.gov |
| Applications of Biocatalytic C–H Functionalization in Complex Molecule Synthesis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,045,595 | July 1, 2018 | November 30, 2028 | RENATA, HANS | reporter.nih.gov |
| Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,034,609 | September 26, 2019 | August 31, 2025 | TAYLOR, HUGH SMITH | reporter.nih.gov |
| Anti-inflammatory Effects of Novel Minor Cannabinoids and Terpenes on Cellular and Murine Models of HIV and HIV Proteins | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,034,538 | September 30, 2020 | July 31, 2025 | PARIS, JASON RICHARD | reporter.nih.gov |
| New Methods for Nitrogen and Oxygen Heterocycle Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,029,619 | July 1, 2006 | December 31, 2024 | CHEMLER, SHERRY R | reporter.nih.gov |
| Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $1,014,698 | March 1, 2024 | December 31, 2028 | BUELL, CAROL ROBIN | reporter.nih.gov |
| Prenatal Tobacco and Cannabis Exposure: A Translational Study | NIH | National Institute on Drug Abuse | 2021 to 2023 | $999,338 | September 30, 2018 | August 31, 2025 | THANOS, PANAYOTIS K | reporter.nih.gov |
| Neonatal cerebral vascular injury by prolonged asphyxia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $997,190 | July 1, 2024 | June 30, 2029 | PARFENOVA, HELENA | reporter.nih.gov |
| Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention | NIH | National Cancer Institute | 2021 to 2023 | $996,514 | February 1, 2019 | January 31, 2025 | WONDRAK, GEORG T | reporter.nih.gov |
| Method and Strategy Development for the Synthesis of Physiologically Important Natural Products | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $993,113 | April 1, 2020 | March 31, 2025 | WOOD, JOHN L | reporter.nih.gov |
| The potential of kava in enabling tobacco cessation - its holistic effects in managing stress and insomnia associated with abstinence | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $984,579 | August 1, 2023 | January 31, 2027 | XING, CHENGGUO | reporter.nih.gov |
| Cannabinoids Modulate Immune Cell-provoked Astrocyte Functions to Suppress HIV-Associated Neuroinflammatory Responses | NIH | National Institute on Drug Abuse | 2022 to 2023 | $976,880 | August 1, 2018 | May 31, 2025 | KAMINSKI, NORBERT E | reporter.nih.gov |
| Expanding the Metabolic Currencies of Life | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $969,365 | June 1, 2024 | March 31, 2029 | LI, HAN | reporter.nih.gov |
| Effects of Early-life Cannabinoid Exposure on Prefrontal Circuitry and Cognitive Behavior across Development | NIH | National Institute on Drug Abuse | 2024 to 2025 | $967,695 | June 1, 2024 | March 31, 2029 | CHE, ALICIA YUE | reporter.nih.gov |
| Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $958,500 | May 1, 2021 | April 30, 2026 | DE AQUINO, JOAO PAULO | reporter.nih.gov |
| Cannabis Toxicology in Relation to Neurocognitive Outcomes in Adolescents | NIH | National Institute on Drug Abuse | 2021 to 2025 | $956,790 | March 15, 2021 | February 28, 2027 | WADE, NATASHA E | reporter.nih.gov |
| microRNA regulation of NMNAT-mediated Neuroprotection against Peripheral Neuropathy and Chronic Pain | NIH | National Center for Complementary & Integrative Health | 2024 | $949,953 | July 10, 2024 | June 30, 2025 | ZHAI, RONG GRACE | reporter.nih.gov |
| Directed evolution of broadly fungible biosensors | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $943,461 | January 5, 2023 | November 30, 2026 | ELLINGTON, ANDREW D | reporter.nih.gov |
| Complement in Paclitaxel-induced peripheral neuropathy | NIH | National Cancer Institute | 2021 to 2024 | $936,532 | March 5, 2020 | February 28, 2026 | XU, JIJUN | reporter.nih.gov |
| 3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $934,920 | September 26, 2019 | August 31, 2025 | GONZALEZ, FRANK | reporter.nih.gov |
| The Effects of Cannabidiol on the Driving Performance of Healthy Adults | NIH | National Institute on Drug Abuse | 2024 to 2025 | $920,550 | September 1, 2024 | May 31, 2029 | RUDISILL, TONI MARIE | reporter.nih.gov |
| Developing natural compound emodin as a therapy for alcoholic cardiomyopathy | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $918,358 | March 15, 2023 | February 28, 2026 | CARVER, WAYNE E | reporter.nih.gov |
| Innovation in Catalyst and Oxidative Amination Reaction Development for the Synthesis of Darobactin and Other Ribosomally Synthesized Post-translationally Modified Peptides (RiPPs) | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $910,532 | September 20, 2020 | August 31, 2024 | BLAKEY, SIMON B. | reporter.nih.gov |
| Exploring the Effects of Cannabinoids on Alcohol Consumption and the Microbiota-Gut-Brain Axis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $909,791 | February 1, 2021 | December 31, 2024 | KAROLY, HOLLIS C | reporter.nih.gov |
| Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis | NIH | National Institute on Drug Abuse | 2025 | $898,025 | April 15, 2025 | February 28, 2030 | BYRAREDDY, SIDDAPPA N | reporter.nih.gov |
| Harnessing divergent reactivities of unusual reactive intermediates as platforms to explore high Fsp3 amine chemical space | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $896,558 | August 1, 2024 | May 31, 2029 | SCHOMAKER, JENNIFER MARIE | reporter.nih.gov |
| Excited-State Catalysis in Organic Synthesis | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $896,285 | August 5, 2016 | June 30, 2023 | NGAI, MING-YU | reporter.nih.gov |
| Investigating the bidirectional relationship between circadian rhythms and cannabinoid use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $887,766 | July 15, 2024 | May 31, 2029 | KETCHESIN, KYLE | reporter.nih.gov |
| Modular synthesis of antibiotic and anticancer classes of natural products | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $887,450 | August 1, 2023 | July 31, 2028 | SEIPLE, IAN BASS | reporter.nih.gov |
| Discovery and Characterization of Manganese-dependent Monooxygenases | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $886,587 | March 15, 2024 | February 28, 2029 | RITTLE, JONATHAN D | reporter.nih.gov |
| Vulnerability and Persistence of Neuroinflammation and Behavioral Deficits from Developmental Cannabinoid Exposure | NIH | National Institute on Drug Abuse | 2024 to 2025 | $885,374 | July 1, 2024 | May 31, 2029 | WILLETT, KRISTINE L | reporter.nih.gov |
| Safety, Feasibility and Efficacy of Sulforaphane in Chronic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $884,203 | September 1, 2021 | June 30, 2025 | LE, THU H. | reporter.nih.gov |
| Combination of THC and CBD as a Novel Treatment for Co-Occurring Opioid Addiction and Chronic Pain | NIH | National Institute on Drug Abuse | 2024 to 2025 | $883,050 | May 1, 2024 | February 28, 2028 | DE AQUINO, JOAO PAULO | reporter.nih.gov |
| Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $873,042 | June 8, 2023 | June 30, 2027 | ZHAO, RUIMING | reporter.nih.gov |
| Mechanisms of Probiotics in Alcoholic Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $854,074 | September 15, 2015 | July 31, 2025 | FENG, WENKE | reporter.nih.gov |
| Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $852,338 | March 17, 2023 | February 28, 2026 | CLARKE, WILLIAM P | reporter.nih.gov |
| Synthetic biology to discover kratom natural product biosynthetic pathways for biased analgesic development | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $847,954 | June 6, 2024 | March 31, 2029 | LI, SIJIN | reporter.nih.gov |
| Chemical biology tools for illuminating cannabinoid signaling pathways in opioid use disorder. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $842,400 | August 15, 2024 | May 31, 2029 | FRANK, JAMES ALLEN | reporter.nih.gov |
| Design, Synthesis, and Evaluation of ant-Glioblastoma Agents | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $830,442 | September 15, 2020 | June 30, 2025 | FLOREANCIG, PAUL E | reporter.nih.gov |
| Natural Phenolic Compounds against Oral Candidiasis (OC) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $817,417 | August 9, 2024 | July 31, 2029 | MYLONAKIS, ELEFTHERIOS | reporter.nih.gov |
| An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $815,161 | August 15, 2024 | September 30, 2027 | DIAS, NICHOLAS | reporter.nih.gov |
| The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy | NIH | National Cancer Institute | 2024 to 2025 | $805,748 | September 1, 2024 | August 31, 2029 | YANG, QING | reporter.nih.gov |
| Gut Microbiota Dysbiosis in Major Depressive Disorder is Associated with Altered Production of Aryl Hydrocarbon Receptor Ligands and Altered Microglia Function | NIH | National Institute of Mental Health | 2021 to 2024 | $804,600 | September 22, 2021 | June 30, 2025 | RAMPERSAUD, RYAN | reporter.nih.gov |
| Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $797,291 | September 15, 2019 | June 30, 2026 | GAMAGE, THOMAS F | reporter.nih.gov |
| Pathophysiological mechanisms of cannabidiol in stress regulation | NIH | National Institute of Mental Health | 2025 | $794,696 | May 1, 2025 | February 28, 2030 | BACHI, KEREN | reporter.nih.gov |
| Quantifying effects of comorbidities and genetics on cannabinoid exposure in the elderly | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $794,611 | August 1, 2022 | February 28, 2026 | ZHOU, ZHU | reporter.nih.gov |
| Hands-on Education and Research for Biomedical and Analytical Learning (HERBAL) | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $788,778 | July 3, 2023 | June 30, 2028 | ROWLEY, DAVID C | reporter.nih.gov |
| Structural Biology of Complex Enzymes | NIH | National Institute of General Medical Sciences | 2025 | $785,056 | February 1, 1990 | August 31, 2027 | SMITH, JANET L. | reporter.nih.gov |
| Splicing Modulators for Rare Disease Indications | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $782,480 | September 1, 2022 | August 31, 2025 | TAYLOR, RICHARD E. | reporter.nih.gov |
| A novel platform for nonribosomal peptide discovery | NIH | National Institute of General Medical Sciences | 2025 | $781,502 | July 1, 2025 | June 30, 2028 | BEHSAZ, BAHAR | reporter.nih.gov |
| Cellular mechanisms of astringency transduction and sensation | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $780,751 | August 1, 2025 | July 31, 2030 | MOAYEDI-ESFAHANI, YALDA | reporter.nih.gov |
| New Methods and Strategies for the Scalable Synthesis of Complex Bioactive Molecules | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $780,000 | August 1, 2024 | May 31, 2029 | ROMITI, FILIPPO | reporter.nih.gov |
| The impact of medical cannabis on pain and inflammation in people living with HIV | NIH | National Institute on Drug Abuse | 2021 to 2024 | $776,700 | July 15, 2021 | February 28, 2026 | SLAWEK, DEEPIKA | reporter.nih.gov |
| New Methods for Nitrogen and Oxygen Heterocycle Synthesis | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $773,357 | July 1, 2024 | April 30, 2029 | CHEMLER, SHERRY R | reporter.nih.gov |
| Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $773,104 | June 1, 2022 | May 31, 2027 | CURTIS, SUSANNA | reporter.nih.gov |
| Fetal neuronal extracellular vesicle biomarkers of in-utero effects of maternal cannabinoid use and human fetal brain development and neurobehavioral outcomes | NIH | National Institute on Drug Abuse | 2025 | $761,367 | September 1, 2025 | May 31, 2030 | GOETZL, LAURA | reporter.nih.gov |
| Computational Exploration of Plant Natural Products Bioactivity and Bioavailability in Human Health | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $749,756 | June 10, 2024 | April 30, 2029 | VERMAAS, JOSHUA V. | reporter.nih.gov |
| Development of new methods and strategies for the synthesis of complex molecules | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $748,404 | March 5, 2024 | January 31, 2029 | PRONIN, SERGEY | reporter.nih.gov |
| Interrogation of Microbial Natural Product Methyltransferases | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $746,999 | July 15, 2021 | June 30, 2025 | DAVIS, TONY D. | reporter.nih.gov |
| Role of Macrophages in CBD mediated attenuation of SEB-induced ARDS | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $746,874 | February 1, 2022 | July 31, 2026 | WILSON, KIESHA | reporter.nih.gov |
| Development of Mirror-Image Natural Products as Antiarrhythmic Therapeutics | NIH | National Heart, Lung, and Blood Institute | 2025 | $744,145 | September 4, 2025 | May 31, 2029 | JOHNSTON, JEFFREY NICHOLAS | reporter.nih.gov |
| Biochemistry of membrane proteins involved in lipid and cannabinoid metabolism | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $743,818 | August 1, 2024 | July 31, 2029 | DAS, ADITI | reporter.nih.gov |
| Predoctoral Training: Innovative Technologies for Natural Products and Integrative Medicine Research | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $742,810 | March 1, 2016 | March 31, 2027 | CECH, NADJA B | reporter.nih.gov |
| Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products | NIH | National Cancer Institute | 2021 to 2024 | $741,335 | July 14, 2020 | June 30, 2025 | FENICAL, WILLIAM | reporter.nih.gov |
| Understanding and manipulating biosynthetic mechanisms for formation of terpenes relevant to human health | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $739,465 | July 15, 2024 | May 31, 2029 | TANTILLO, DEAN | reporter.nih.gov |
| Defining the impact of cannabinoids on the HIV reservoir in humanized mice | NIH | National Institute on Drug Abuse | 2025 | $738,616 | September 30, 2023 | July 31, 2028 | BROWNE, EDWARD P | reporter.nih.gov |
| Mechanistic studies of the menthol receptor TRPM8: a novel target for analgesic drugs | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $738,361 | September 1, 2019 | August 31, 2024 | DIVER, MELINDA | reporter.nih.gov |
| From Genes to Molecules and Back: Expanding the Chemical Space of Microbial and Microbiome Natural Products | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $738,000 | September 1, 2024 | August 31, 2029 | SEYEDSAYAMDOST, MOHAMMAD R | reporter.nih.gov |
| Development of novel computational protocols to study amyloid oligomerization | NIH | National Institute on Aging | 2021 to 2025 | $736,374 | August 15, 2021 | July 31, 2027 | MAN, VIET HOANG | reporter.nih.gov |
| Identification of Biomarkers of Plant-Rich Diets and Carbonyl Stress and Their Associations with Cardiovascular Risk | NIH | National Heart, Lung, and Blood Institute | 2025 | $733,785 | September 15, 2025 | June 30, 2030 | HU, FRANK B | reporter.nih.gov |
| An LCMS-guided bioanalytical approach for rational natural product library design and optimization | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $730,689 | September 5, 2022 | June 30, 2027 | MCCALL, LAURA-ISOBEL | reporter.nih.gov |
| Chemical synthesis to access rare heterocycles and tool compounds to probe bacterial polysaccharide metabolism | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $721,207 | September 1, 2024 | June 30, 2029 | WHITEHEAD, DANIEL CHARLES | reporter.nih.gov |
| A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression | NIH | National Cancer Institute | 2025 | $717,150 | January 1, 2025 | December 31, 2029 | YEARY, KAREN HYE-CHEON KIM | reporter.nih.gov |
| Oral THC consumption during adolescence and its impact on adult mouse brain | NIH | National Institute on Drug Abuse | 2025 | $716,455 | July 1, 2025 | March 31, 2030 | STELLA, NEPHI | reporter.nih.gov |
| Biosynthesis of Unusual Bio-Orthogonal Functionalities in Natural Products | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $716,231 | April 1, 2024 | March 31, 2029 | ZHANG, WENJUN | reporter.nih.gov |
| Influence of microbial metabolites on mitosome function in Cryptosporidium | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $715,894 | August 8, 2025 | July 31, 2030 | SIBLEY, L. DAVID | reporter.nih.gov |
| Convergent Evolution in Natural Product Biosynthesis | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $713,639 | August 1, 2024 | May 31, 2029 | NEWTON, CHRISTOPHER | reporter.nih.gov |
| Bioactive natural product discovery from human oral microbes | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $707,318 | February 16, 2024 | January 31, 2029 | ZHANG, WENJUN | reporter.nih.gov |
| Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy | NIH | National Cancer Institute | 2024 to 2025 | $702,262 | April 4, 2024 | March 31, 2029 | XU, XIANGXI MIKE | reporter.nih.gov |
| C. officinalis induction of Nrf2 inhibiting type 1 diabetes | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $699,848 | March 25, 2024 | December 31, 2028 | BURKHARDT, BRANT ROGER | reporter.nih.gov |
| Developing ribosome biogenesis inhibitors for the prevention of cancer | NIH | National Cancer Institute | 2024 to 2025 | $697,000 | May 21, 2024 | April 30, 2027 | BUSZCZAK, MICHAEL | reporter.nih.gov |
| Indole Metabolites as Xenobiotic Danger signals in Acute Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2025 | $688,163 | September 1, 2025 | May 31, 2029 | EVANKOVICH, JOHN W | reporter.nih.gov |
| Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $676,000 | July 15, 2022 | June 30, 2024 | STEWART, ANDREW F. | reporter.nih.gov |
| Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $672,377 | September 20, 2025 | August 31, 2030 | WOLINSKY, DAVID | reporter.nih.gov |
| Characterizing the Epidemiology of Cannabidiol (CBD) Use Among US adults | NIH | National Institute on Drug Abuse | 2022 to 2025 | $668,431 | April 1, 2022 | March 31, 2027 | LEAS, ERIC | reporter.nih.gov |
| Nautral products for targeting Skp2 in cancer interception | NIH | National Cancer Institute | 2024 to 2025 | $667,250 | June 1, 2024 | April 30, 2027 | ZI, XIAOLIN | reporter.nih.gov |
| Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors | NIH | National Cancer Institute | 2024 to 2025 | $657,145 | May 14, 2024 | April 30, 2027 | CAO, SHUGENG | reporter.nih.gov |
| Expanding Access to Molecular Complexity through Natural Product Synthesis | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $656,000 | August 1, 2024 | May 31, 2029 | SMITH, MYLES WARWICK | reporter.nih.gov |
| Nanoparticles with Two-Stage Delivery of Tetrodotoxin for Prolonged Duration Local Anesthesia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $652,659 | June 21, 2022 | May 31, 2024 | ZHAO, CHAO | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of California, San Diego | La Jolla, CA | 30 | $39.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 23 | $34.7 million | 0 | $0 |
| University of Florida | Gainesville, FL | 16 | $32.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 19 | $29.8 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 16 | $27 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 28 | $26.5 million | 0 | $0 |
| Yale University | New Haven, CT | 15 | $25.4 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 8 | $22.8 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 14 | $22.2 million | 0 | $0 |
| Psychogenics, Inc. | Paramus, NJ | 1 | $21.3 million | 0 | $0 |
| Marshall University Research Corporation | Huntington, WV | 1 | $20.3 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 11 | $20.2 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 14 | $17.8 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 15 | $17.2 million | 0 | $0 |
| University of Delaware | Newark, DE | 3 | $16.3 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 10 | $16.1 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 8 | $15.9 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 11 | $14.2 million | 0 | $0 |
| Emory University | Atlanta, GA | 13 | $14.1 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 16 | $13.8 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 10 | $13.6 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 13 | $13.4 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 9 | $12.9 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 4 | $12.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 8 | $12.1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 5 | $11 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 10 | $10.6 million | 0 | $0 |
| Duke University | Durham, NC | 3 | $9.9 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 10 | $9.5 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 11 | $9.4 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 3 | $9.4 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 3 | $8.9 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 3 | $8.5 million | 0 | $0 |
| University of Washington | Seattle, WA | 9 | $8.4 million | 0 | $0 |
| Sparian Biosciences, Inc. | New York City, NY | 1 | $7.9 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 5 | $7.8 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 5 | $7.6 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 4 | $7.4 million | 0 | $0 |
| Stanford University | Stanford, CA | 5 | $7.3 million | 0 | $0 |
| Fisher Bioservices, Inc. | Rockville, MD | 1 | $7.2 million | 0 | $0 |
| Northwestern University | Chicago, IL | 3 | $7.2 million | 0 | $0 |
| Curza INC | Salt Lake City, UT | 3 | $6.9 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 5 | $6.8 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 4 | $6.8 million | 0 | $0 |
| University of California-Santa Cruz | Santa Cruz, CA | 3 | $6.8 million | 0 | $0 |
| Trustees of Boston University | Boston, MA | 3 | $6.7 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 6 | $6.7 million | 0 | $0 |
| California Institute of Technology | Pasadena, CA | 8 | $6.5 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 5 | $6.1 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 3 | $6.1 million | 0 | $0 |
| Wayne State University | Detroit, MI | 3 | $6 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 4 | $6 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 3 | $5.7 million | 0 | $0 |
| University of Chicago | Chicago, IL | 7 | $5.7 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 2 | $5.3 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 4 | $5.3 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 2 | $5.1 million | 0 | $0 |
| Texas Biomedical Research Institute | San Antonio, TX | 2 | $5.1 million | 0 | $0 |
| The University of Central Florida Board of Trustees | Orlando, FL | 3 | $4.9 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 7 | $4.9 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 3 | $4.8 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 5 | $4.8 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 5 | $4.7 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 3 | $4.6 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 6 | $4.6 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 2 | $4.4 million | 0 | $0 |
| Boston College | Chestnut Hill, MA | 2 | $4.3 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 3 | $4.3 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 2 | $4 million | 0 | $0 |
| Ohio State University | Columbus, OH | 5 | $4 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 3 | $4 million | 0 | $0 |
| Oregon State University | Corvallis, OR | 6 | $3.9 million | 0 | $0 |
| Rockefeller University | New York, NY | 2 | $3.9 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 2 | $3.9 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 4 | $3.9 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 3 | $3.8 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 2 | $3.8 million | 0 | $0 |
| University of Mississippi | University, MS | 4 | $3.8 million | 0 | $0 |
| Georgia Tech Research Corporation | Atlanta, GA | 3 | $3.7 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 4 | $3.7 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 3 | $3.6 million | 0 | $0 |
| Texas A&M Engineering Experiment Station | College Station, TX | 2 | $3.6 million | 0 | $0 |
| Gilgamesh Pharmaceuticals INC | New York, NY | 1 | $3.6 million | 0 | $0 |
| Augusta University | Augusta, GA | 3 | $3.5 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 4 | $3.5 million | 0 | $0 |
| University of Alabama Tuscaloosa | Tuscaloosa, AL | 5 | $3.5 million | 0 | $0 |
| Roswell Park Cancer Institute Corp | Buffalo, NY | 2 | $3.4 million | 0 | $0 |
| Iowa State University | Ames, IA | 3 | $3.4 million | 0 | $0 |
| Baylor University | Waco, TX | 3 | $3.4 million | 0 | $0 |
| Georgetown University | Washington, DC | 2 | $3.4 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 2 | $3.4 million | 0 | $0 |
| University of California at Davis | Davis, CA | 3 | $3.3 million | 0 | $0 |
| Indiana University | Bloomington, IN | 2 | $3.3 million | 0 | $0 |
| University of Notre Dame | Notre Dame, IN | 2 | $3.3 million | 0 | $0 |
| Battelle Pacific Northwest Laboratories | Richland, WA | 1 | $3.3 million | 0 | $0 |
| Florida International University | Miami, FL | 4 | $3.3 million | 0 | $0 |
| William Marsh Rice University | Houston, TX | 5 | $3.3 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 1 | $3.2 million | 0 | $0 |
| Queen's Medical Center | Honolulu, HI | 1 | $3.2 million | 0 | $0 |
| Integrated Laboratory Systems, LLC | Research Triangle Park, NC | 1 | $3.1 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 492 | $269,126,592 | 0 | $0 |
| 2024 | 557 | $286,478,704 | 0 | $0 |
| 2023 | 551 | $257,088,330 | 0 | $0 |
| 2022 | 395 | $185,166,573 | 0 | $0 |
| 2021 | 261 | $130,831,622 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.